Novo Holdings A/S - VERONA PHARMA PLC ownership

VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 38 filers reported holding VERONA PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q2 2022$3,189,000
-16.0%
761,2050.0%0.16%
-21.5%
Q1 2022$3,798,000
-25.7%
761,2050.0%0.20%
-17.4%
Q4 2021$5,115,000
+22.6%
761,2050.0%0.24%
+12.0%
Q3 2021$4,171,000
-16.2%
761,2050.0%0.22%
-2.3%
Q2 2021$4,978,000
-29.0%
761,205
-9.2%
0.22%
-23.5%
Q1 2021$7,009,000
-61.6%
838,360
-67.9%
0.29%
-63.1%
Q4 2020$18,261,000
+62.5%
2,608,755
+44.9%
0.78%
+40.3%
Q3 2020$11,237,000
+224.1%
1,800,747
+143.1%
0.56%
+149.1%
Q2 2020$3,467,000
+13.6%
740,7400.0%0.22%
+9.8%
Q1 2020$3,052,000
-28.3%
740,7400.0%0.20%
-25.5%
Q4 2019$4,259,000
+25.8%
740,7400.0%0.27%
-52.8%
Q3 2019$3,385,000
-10.4%
740,7400.0%0.58%
+9.6%
Q2 2019$3,778,000
-21.5%
740,7400.0%0.53%
-25.7%
Q1 2019$4,815,000
-32.6%
740,7400.0%0.71%
-29.2%
Q4 2018$7,148,000
-22.9%
740,7400.0%1.01%
+36.7%
Q3 2018$9,267,000
-8.4%
740,7400.0%0.74%
-27.6%
Q2 2018$10,119,000
-31.7%
740,7400.0%1.02%
-45.3%
Q1 2018$14,815,000
+68.5%
740,7400.0%1.86%
+50.7%
Q4 2017$8,793,000
-22.7%
740,7400.0%1.23%
-16.7%
Q3 2017$11,370,000
+31.6%
740,7400.0%1.48%
+43.3%
Q2 2017$8,637,000740,7401.03%
Other shareholders
VERONA PHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Abingworth LLP 2,457,499$16,932,0005.79%
Aisling Capital Management LP 1,332,485$9,327,0001.60%
Ghost Tree Capital, LLC 810,000$5,670,0001.26%
Vivo Capital, LLC 3,048,507$21,340,0000.95%
NEA Management Company, LLC 5,108,563$35,760,0000.94%
Novo Holdings A/S 2,608,755$18,261,0000.78%
Samsara BioCapital, LLC 1,111,112$7,778,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 1,033,603$7,235,0000.64%
RA Capital Management 5,100,000$31,824,0000.44%
Orbimed Advisors 5,694,841$39,864,0000.35%
View complete list of VERONA PHARMA PLC shareholders